Evidence map›Paper›PMID 36825093›Full record

ArticleCase reports in oncology

Cervical Liposarcoma Revisited: A Case Report and Scoping Literature Review.

Takahiro Suzuki, Naoya Noguchi, Shion Shirane, Nanako Ansai, Teruyuki Sato, Kazue Ise, Keigo Murakami, Kazuhiro Murakami, Yasuhiro Nakamura, Nobuo Ohta

Open access · goldAbstract readCase ReportsScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Takahiro SuzukiaDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Naoya NoguchiaDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Shion ShiraneaDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Nanako AnsaiaDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Teruyuki SatoaDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kazue IsebTechnical Services Division, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Keigo MurakamicDivision of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kazuhiro MurakamicDivision of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Yasuhiro NakamuracDivision of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Nobuo OhtaaDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Tohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The commonest sites for liposarcoma are the retroperitoneum and lower extremities. Liposarcoma of the head and neck region is a rare and potentially life-threatening malignancy. Tumors originating in the right cervical space cause special diagnostic and therapeutic difficulties. In the present report, we describe a case of differentiated liposarcoma of the right cervical region. The tumor continued to grow slowly over 3 years before a definitive diagnosis was established. Extended extirpation of the tumor was performed and proved efficacious in that no recurrence has been observed for 4 years. Recommendations for earlier and accurate diagnosis and treatment of this rare neoplasm are discussed.

Indexed as

Cervical liposarcomaCyclin-dependent kinase 4Murine double minute 2

Identifiers

PMID36825093
PMCPMC9941791
OpenAlexW4300816927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.